These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 31091274)

  • 1. Ninjurin1 regulates striated muscle growth and differentiation.
    Kny M; Csályi KD; Klaeske K; Busch K; Meyer AM; Merks AM; Darm K; Dworatzek E; Fliegner D; Baczko I; Regitz-Zagrosek V; Butter C; Luft FC; Panáková D; Fielitz J
    PLoS One; 2019; 14(5):e0216987. PubMed ID: 31091274
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prolonged endoplasmic reticulum stress in hypertrophic and failing heart after aortic constriction: possible contribution of endoplasmic reticulum stress to cardiac myocyte apoptosis.
    Okada K; Minamino T; Tsukamoto Y; Liao Y; Tsukamoto O; Takashima S; Hirata A; Fujita M; Nagamachi Y; Nakatani T; Yutani C; Ozawa K; Ogawa S; Tomoike H; Hori M; Kitakaze M
    Circulation; 2004 Aug; 110(6):705-12. PubMed ID: 15289376
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeted disruption of Hspa4 gene leads to cardiac hypertrophy and fibrosis.
    Mohamed BA; Barakat AZ; Zimmermann WH; Bittner RE; Mühlfeld C; Hünlich M; Engel W; Maier LS; Adham IM
    J Mol Cell Cardiol; 2012 Oct; 53(4):459-68. PubMed ID: 22884543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiac-specific Traf2 overexpression enhances cardiac hypertrophy through activating AKT/GSK3β signaling.
    Huang Y; Wu D; Zhang X; Jiang M; Hu C; Lin J; Tang J; Wu L
    Gene; 2014 Feb; 536(2):225-31. PubMed ID: 24378234
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The alteration of protein prenylation induces cardiomyocyte hypertrophy through Rheb-mTORC1 signalling and leads to chronic heart failure.
    Xu N; Guan S; Chen Z; Yu Y; Xie J; Pan FY; Zhao NW; Liu L; Yang ZZ; Gao X; Xu B; Li CJ
    J Pathol; 2015 Apr; 235(5):672-85. PubMed ID: 25385233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tripartite Motif 8 Contributes to Pathological Cardiac Hypertrophy Through Enhancing Transforming Growth Factor β-Activated Kinase 1-Dependent Signaling Pathways.
    Chen L; Huang J; Ji YX; Mei F; Wang PX; Deng KQ; Jiang X; Ma G; Li H
    Hypertension; 2017 Feb; 69(2):249-258. PubMed ID: 27956576
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decompensation of pressure-overload hypertrophy in G alpha q-overexpressing mice.
    Sakata Y; Hoit BD; Liggett SB; Walsh RA; Dorn GW
    Circulation; 1998 Apr; 97(15):1488-95. PubMed ID: 9576430
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of microRNA-99a Attenuates Cardiac Hypertrophy.
    Li Q; Xie J; Wang B; Li R; Bai J; Ding L; Gu R; Wang L; Xu B
    PLoS One; 2016; 11(2):e0148480. PubMed ID: 26914935
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel role for caspase-activated DNase in the regulation of pathological cardiac hypertrophy.
    Gao L; Huang K; Jiang DS; Liu X; Huang D; Li H; Zhang XD; Huang K
    Hypertension; 2015 Apr; 65(4):871-81. PubMed ID: 25646292
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypoxia-Induced Mitogenic Factor Promotes Cardiac Hypertrophy via Calcium-Dependent and Hypoxia-Inducible Factor-1α Mechanisms.
    Kumar S; Wang G; Liu W; Ding W; Dong M; Zheng N; Ye H; Liu J
    Hypertension; 2018 Aug; 72(2):331-342. PubMed ID: 29891648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blockade of MyD88 attenuates cardiac hypertrophy and decreases cardiac myocyte apoptosis in pressure overload-induced cardiac hypertrophy in vivo.
    Ha T; Hua F; Li Y; Ma J; Gao X; Kelley J; Zhao A; Haddad GE; Williams DL; Browder IW; Kao RL; Li C
    Am J Physiol Heart Circ Physiol; 2006 Mar; 290(3):H985-94. PubMed ID: 16199478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adapter molecule DOC-2 is differentially expressed in pressure and volume overload hypertrophy and inhibits collagen synthesis in cardiac fibroblasts.
    Kumbar DH; VanBergen A; Ocampo C; Muangmingsuk S; Griffin AJ; Gupta M
    J Appl Physiol (1985); 2007 May; 102(5):2024-32. PubMed ID: 17255372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Raf-1 kinase is required for cardiac hypertrophy and cardiomyocyte survival in response to pressure overload.
    Harris IS; Zhang S; Treskov I; Kovacs A; Weinheimer C; Muslin AJ
    Circulation; 2004 Aug; 110(6):718-23. PubMed ID: 15289381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiotensin-converting enzyme inhibition prolongs survival and modifies the transition to heart failure in rats with pressure overload hypertrophy due to ascending aortic stenosis.
    Weinberg EO; Schoen FJ; George D; Kagaya Y; Douglas PS; Litwin SE; Schunkert H; Benedict CR; Lorell BH
    Circulation; 1994 Sep; 90(3):1410-22. PubMed ID: 8087951
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myocardial Hypertrophic Preconditioning Attenuates Cardiomyocyte Hypertrophy and Slows Progression to Heart Failure Through Upregulation of S100A8/A9.
    Wei X; Wu B; Zhao J; Zeng Z; Xuan W; Cao S; Huang X; Asakura M; Xu D; Bin J; Kitakaze M; Liao Y
    Circulation; 2015 Apr; 131(17):1506-17; discussion 1517. PubMed ID: 25820336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of myocardial changes between pressure induced hypertrophy and normal growth in the rat heart.
    van der Laarse A; Vliegen HW; van der Nat KH; Hollaar L; Egas JM; Swier GP; van den Broek AJ
    Cardiovasc Res; 1989 Apr; 23(4):308-14. PubMed ID: 2531632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adiponectin is required for cardiac MEF2 activation during pressure overload induced hypertrophy.
    Dadson K; Turdi S; Hashemi S; Zhao J; Polidovitch N; Beca S; Backx PH; McDermott JC; Sweeney G
    J Mol Cell Cardiol; 2015 Sep; 86():102-9. PubMed ID: 26196305
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Type III Transforming Growth Factor-β Receptor Drives Cardiac Hypertrophy Through β-Arrestin2-Dependent Activation of Calmodulin-Dependent Protein Kinase II.
    Lou J; Zhao D; Zhang LL; Song SY; Li YC; Sun F; Ding XQ; Yu CJ; Li YY; Liu MT; Dong CJ; Ji Y; Li H; Chu W; Zhang ZR
    Hypertension; 2016 Sep; 68(3):654-66. PubMed ID: 27432858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progression from compensated hypertrophy to failure in the pressure-overloaded human heart: structural deterioration and compensatory mechanisms.
    Hein S; Arnon E; Kostin S; Schönburg M; Elsässer A; Polyakova V; Bauer EP; Klövekorn WP; Schaper J
    Circulation; 2003 Feb; 107(7):984-91. PubMed ID: 12600911
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rho-kinase inhibition reverses impaired Ca
    Olgar Y; Celen MC; Yamasan BE; Ozturk N; Turan B; Ozdemir S
    Cell Calcium; 2017 Nov; 67():81-90. PubMed ID: 29029794
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.